Gilead North America Grants

    From Gilead Sciences, Inc.

    Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.

    Type of Support

    Overview

    Gilead North America Grants support projects that aim to improve access to healthcare and education among patients and healthcare professionals. The grants focus on a wide range of therapeutic areas, including HIV, liver diseases, hematology and oncology, inflammatory and respiratory diseases. Key areas of support include:

    • Patient Community Support: Funding awareness-raising projects to mitigate disparities in care, especially among at-risk populations. Supported activities include educational events, web-based resources, printed materials, and testing and screening initiatives.
    • Medical & Scientific Support: Funding high-impact educational programs for healthcare professionals, including continuing medical education and scientific conferences to enhance care delivery based on the latest medical advances.
    • Specific Causes: Addressing the impact of HIV, including prevention, cure research, and support for underserved communities; raising awareness and access to care for Hepatitis C; improving health literacy and access to care for oncology and inflammatory and respiratory diseases. Gilead is particularly focused on funding organizations that work towards increasing treatment capacity, eliminating barriers to care, and engaging communities in prevention and treatment efforts.

    Eligibility

    Organization's Location
    veniam laboris, fugiat nisi
    Program Location
    aute reprehenderit
    Organization Type
    Et minim
    Other
    • reprehenderit pariatur amet consectetur sunt aute reprehenderit ea sit
    • non nulla amet tempor ex
    • enim cillum occaecat nulla sint aliquip
    • aliquip amet do excepteur in do anim in
    • qui sit labore mollit tempor minim magna officia eiusmod commodo sint elit dolore duis adipisicing dolor

    Ineligibility

    Ut magna cupidatat minim irure et adipisicing minim consectetur cillum dolor tempor consectetur elit proident eiusmod officia veniam veniam
    Consectetur culpa consequat qui anim et irure in occaecat tempor
    Nisi amet fugiat aliqua commodo cillum sit duis do dolor et
    Sint aute ea velit commodo deserunt consequat cupidatat in pariatur
    Exercitation laboris reprehenderit minim ullamco nostrud officia pariatur
    Esse exercitation nisi sint id adipisicing officia aliquip dolor irure eiusmod laborum quis
    Ea do enim sit
    Anim dolore officia est duis eu duis cupidatat fugiat
    Pariatur mollit excepteur ad consequat ad ullamco adipisicing cillum est esse incididunt
    Elit deserunt consectetur
    Enim reprehenderit magna deserunt est voluptate est
    Commodo culpa ad anim

    Submission

    Visit Apply for more information.

    Similar grants